Sweden - Healthcare, Regulatory and Reimbursement Landscape
Summary
GlobalData, the industry analysis specialist, has released its latest report, “Sweden - Healthcare, Regulatory and Reimbursement Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Sweden. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.
The Swedish pharmaceutical market, in terms of Swedish Krona was valued at SEK36.11B in 2012, which increased at a CAGR of 4.78% to SEK50.09B in 2019. In terms of US dollars, it was valued at $5.33B in 2012, which decreased at a negative CAGR of 0.09% to $5.30B in 2019. The market value is expected to remain flat in terms of US dollars and is estimated to reach $5.27B by 2024. The growth in the pharmaceutical market is attributed to the growing aging population; lifestyle-related disease conditions such as diabetes and obesity; and increased prevalence of chronic diseases such as cardiovascular conditions, strokes, and cancer. Generics substitution and low pricing are barriers to the growth of the Swedish pharmaceutical market.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Sweden, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, AstraZeneca, Fresenius Kabi, Octapharma, and Sobi
- Profiles and SWOT analyses of the major players in the medical device market: Abbott, Medtronic, DePuy Synthes, Alcon, and Getinge
- An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Sweden healthcare market
Reasons to BuyThis report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Sweden’s healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Sweden’s healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership
- 1. Table of Contents
- 1.1 List of Figures
- 1.2 List of Tables
- 2. Executive Summary
- 2.1 Executive Summary
- 2.2 Key Highlights - Facts about the Swedish Healthcare Market
- 2.3 Key Highlights: Healthcare Startups in Sweden
- 2.4 Key Events: Swedish Healthcare Timeline, 2014-2020
- 2.5 Key Events: Swedish Pharmaceutical Market
- 2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019-2020
- 2.7 Key Events: Mergers and Acquisitions
- 2.8 Country Profile, Sweden, 2019
- 3. Overview of Pharmaceutical Market
- 3.1 Pharmaceutical Market - Overview
- 3.2 Pharmaceutical Market - Exports
- 3.3 Pharmaceutical Market - Imports
- 3.4 Pharmaceutical Market - Supply Channels, Sweden
- 3.5 Pharmaceutical Market - Market Segments
- 3.6 Major Therapeutic Areas, Sweden
- 3.7 COVID-19 Epidemiology, Sweden
- 3.8 COVID-19 Impact and Developments in the Healthcare Market, Sweden
- 3.9 COVID-19 Clinical Trials Landscape, Sweden
- 3.10 Pharmaceutical Market - Major Players
- 4. Overview of Medical Devices Market
- 4.1 Medical Device Market - Overview
- 4.2 Medical Devices Market - Major Players
- 5. Pharmaceutical and Medical Devices Market - Drivers and Barriers
- 5.1 Drivers
- 5.2 Barriers
- 6. Deal Analysis
- 6.1 Deal Analysis: Pharmaceutical Market, Sweden, 2019-2020
- 6.2 Deal Analysis: Medical Device Market, Sweden, 2019-2020
- 7. HealthTech Landscape
- 7.1 HealthTech Deals Landscape, Sweden
- 7.2 Key HealthTech Deals, Sweden
- 7.3 Adoption of Technology in Healthcare, Sweden
- 7.4 Regulatory Scenario Covering Use of Technology in Healthcare, Sweden
- 7.5 HealthTech Landscape: Benefits and Risks, Sweden
- 8. Market Access
- 8.1 Overview of Healthcare System, Sweden
- 8.2 Reimbursement Process, Sweden
- 8.3 Overview of Insurance Providers, Sweden
- 8.4 Healthcare Spending and Medicine Price Index, Sweden
- 8.5 Pricing Policies, Sweden
- 8.6 Regulatory Landscape, Sweden
- 8.6.1 Overview of Regulatory Agencies
- 8.6.2 Marketing Authorization for Pharmaceutical Products, EU
- 8.6.3 Marketing Authorization for Pharmaceutical Products, National Procedure, Sweden
- 8.6.4 Marketing Authorization for Pharmaceutical Products, Centralized Procedure, Sweden
- 8.6.5 Marketing Authorization for Pharmaceutical Products, Decentralized Procedure, Sweden
- 8.6.6 Marketing Authorization for Pharmaceutical Products, Mutual Recognition Procedure, Sweden
- 8.6.7 Market Authorization for Medical Devices, Sweden
- 8.6.8 Intellectual Property Rights, Patent, Sweden
- 8.6.9 Intellectual Property Rights, European Patent, Sweden
- 8.6.10 Intellectual Property Rights, Unitary Patent, Sweden
- 8.6.11 Intellectual Property Rights, Trademark, Sweden
- 8.6.12 Clinical Trials Regulation, Sweden
- 8.6.13 Pharmaceutical Clinical Trials Landscape, Sweden
- 8.6.14 Medical Devices Clinical Trials Landscape, Sweden
- 8.6.15 Licensing Process for Pharmaceutical Manufacturing, Sweden
- 8.6.16 Licensing Process for Pharmaceutical Exports and Imports
- 8.6.17 Pharmaceutical Advertisement Regulations, Sweden
- 8.6.18 Labeling and Packaging Regulations, Sweden
- 9. Country Healthcare Landscape
- 9.1 Swedish Healthcare Policy Highlights
- 9.2 Healthcare Facilities, Sweden
- 9.3 Healthcare Parameters, Sweden
- 9.4 Life Expectancy and Immunization Rate, Sweden
- 9.5 Environmental Health, Sweden
- 9.6 Healthcare Personnel, Sweden
- 9.7 Disease Burden, Sweden
- 9.8 Healthcare Expenditure, Sweden
- 10 Trade Associations, Sweden
- 11 Trade Fairs, Sweden
- 12 Opportunities and Challenges
- 13 Appendix
- List of Tables
- Table 1: Approved Biosimilars, EU, 2019-2020
- Table 2: Pharmaceutical Market, Sweden, Sales of Patented Drug Products (by Major Therapeutic Class) ($M), 2019
- Table 3: COVID-19 Indicators (Number of Cases), Global and Sweden, 2020
- Table 4: COVID-19 IVD Products, Sweden, 2020
- Table 5: Medical Device Market, Sweden, Major Segments ($M), 2019
- Table 6: Orthopedic Devices Market, Sweden, Revenue ($M) and Market Share (%) of Major Companies, 2019
- Table 7: Cardiovascular Devices Market, Sweden, Revenue ($M) and Market Share (%) of Major Companies, 2019
- Table 8: General Surgery Market, Sweden, Revenue ($M) and Market Share (%) of Major Companies, 2019
- Table 9: Wound Care Management Market, Sweden, Revenue ($M) and Market Share (%) of Major Companies, 2019
- Table 10: Diabetes Care Devices Market, Sweden, Revenue ($M) and Market Share (%) of Major Companies, 2019
- Table 11: Role of the Healthcare Authorities, Sweden, 2020
- Table 12: Benefits Associated with SSIA, Sweden, 2017
- Table 13: Pricing of Medicines at Different Levels, Sweden, 2017
- Table 14: MA Application Type and Fees, Sweden, 2019
- Table 15: MA Annual Fees, Sweden, 2019
- Table 16: Medical Devices Registration Fees, Sweden, 2020
- Table 17: Patent Fees, Sweden, 2020
- Table 18: Trademark Fees, Sweden, 2020
- Table 19: Advertising Regulations, Sweden, 2020
- Table 20: Advertising of Pharmaceutical Products Through Other Mass Media, Sweden, 2020
- Table 21: Label of Outer Packaging And Medicine Containers, Sweden, 2020
- Table 22: Label of Pharmaceutical Blister, Sweden, 2020
- Table 23: Label of Small Pharmaceutical Packaging, Sweden, 2020
- List of Figures
- Figure 1: Pharmaceutical Market, Sweden, Revenue ($B), 2012-2019
- Figure 2: Medical Device Market, Sweden, Revenue ($B), 2015-2020
- Figure 3: Healthcare Startups in Sweden, 2020
- Figure 4: Number of Deals (2019-2020)
- Figure 5: 2019-2020 Deal Overview by Region
- Figure 6: Country Profile, Sweden, 2019
- Figure 7: Pharmaceutical Market, Sweden, Revenue ($B), 2012-2019
- Figure 8: Pharmaceutical Market, Sweden, Revenue Forecast ($B), 2020-2024
- Figure 9: Pharmaceutical Exports ($B), Sweden, 2012-2019
- Figure 10: Top Export Partners, Sweden, 2019
- Figure 11: Pharmaceutical Imports ($B), Sweden, 2012-2019
- Figure 12: Top Import Partners, Sweden, 2019
- Figure 13: Pharmaceutical Supply Channel, Sweden, 2019
- Figure 14: Pharmacy Market Share Based on the Number of Pharmacies, Sweden, 2012-2019
- Figure 15: OTC Market, Sweden, Revenue ($B), 2012-2019
- Figure 16: OTC Market by Drug Category, Sweden, Revenue ($M), 2019
- Figure 17: Pharmaceutical Market, Sweden, Sales of Patented Drug Products (by Major Therapeutic Class), 2019
- Figure 18: COVID-19 (Cases), Sweden, 2020
- Figure 19: COVID-19 (Deaths), Sweden, 2020
- Figure 20: COVID-19 Clinical Trials Count (by Trial Status), Sweden, 2020
- Figure 21: COVID-19 Clinical Trials Count (by Phase), Sweden, 2020
- Figure 22: Top Five COVID-19 Clinical Trials Sponsors (by Count), Sweden, 2020
- Figure 23: Medical Device Market, Sweden, Revenue ($B), 2015-2020
- Figure 24: Medical Device Market, Sweden, Revenue Forecast ($B), 2021-2025
- Figure 25: Medical Device Market, Sweden, Major Segments (%), 2019
- Figure 26: Orthopedic Devices Market, Sweden, Revenue ($M), 2015-2022
- Figure 27: Orthopedic Devices Market, Sweden, Market Share of Major Players (%), 2019
- Figure 28: Cardiovascular Devices Market, Sweden, Revenue ($M), 2015-2022
- Figure 29: Cardiovascular Devices Market, Sweden, Market Share of Major Players (%), 2019
- Figure 30: General Surgery Market, Sweden, Revenue ($M), 2015-2022
- Figure 31: General Surgery Market, Sweden, Market Share of Major Players (%), 2019
- Figure 32: Wound Care Management Market, Sweden, Revenue ($M), 2015-2022
- Figure 33: Wound Care Management Market, Sweden, Market Share of Major Players (%), 2019
- Figure 34: Diabetes Care Devices Market, Sweden, Revenue ($M), 2015-2022
- Figure 35: Diabetes Care Devices Market, Sweden, Market Share of Major Players (%), 2019
- Figure 36: Diagnostic Market, Sweden, Revenue ($M), 2015-2020
- Figure 37: Diagnostic Market, Sweden, Revenue ($M), 2021-2025
- Figure 38: Medical Devices Market, Revenue ($B) of Major Companies, Sweden, 2019
- Figure 39: Deal Value and Deal Count, Pharmaceutical Market, Sweden, 2019-2020
- Figure 40: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Sweden, 2019-2020
- Figure 41: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Sweden, 2019-2020
- Figure 42: Top Five Therapy Areas (by Deal Value), Pharmaceutical Market, Sweden, 2019-2020
- Figure 43: Top Five Therapy Areas (by Deal Number), Pharmaceutical Market, Sweden, 2019-2020
- Figure 44: M&A Deals by Therapy Area, Pharmaceutical Market, Sweden, 2019-2020 (by Value ($M) and Number)
- Figure 45: PE Deals by Therapy Area, Pharmaceutical Market, Sweden, 2019-2020 (by Value ($M) and Number)
- Figure 46: VC Deals by Therapy Area, Pharmaceutical Market, Sweden, 2019-2020 (by Value ($M) and Number)
- Figure 47: Medical Devices Market Deals (by Deal Value, $M), Sweden, 2019-2020
- Figure 48: Medical Devices Market Deals (by Deal Count), Sweden, 2019-2020
- Figure 49: Medical Devices Market Deals Share (by Deal Value), Sweden, 2019-2020
- Figure 50: Medical Devices Market Deals Share (by Deal Count), Sweden, 2019-2020
- Figure 51: Medical Devices, Top Therapy Area (by Deal Value), Sweden, 2019-2020